NDRA
ENDRA Life Sciences Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
ENDRA Life Sciences Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No changes.
No changes.
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Largest filed tie
0
filed ties
—
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; no measured co-movers for ENDRA Life Sciences Inc..
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; no measured co-movers for ENDRA Life Sciences Inc..
ENDRA Life Sciences Inc.
4.43
−0.51 · −10.32%
post 4.43 0.00%
Tall tick = annual report · Source: EDGAR
Expected move
No implied move.
+6.30%
shares held · 7 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Altium | $315,920 | 38.57% | +14.20% |
| Citadel | $159,495 | 19.47% | new |
| Citizens Financial | $151,372 | 18.48% | new |
| Geodeindex-like | $79,470 | 9.70% | −29.26% |
| Vanguard Fiduciary Trustindex-like | $53,945 | 6.59% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| Altium | $315,920 | 38.57% | +14.20% |
| Citadel | $159,495 | 19.47% | new |
| Citizens Financial | $151,372 | 18.48% | new |
| Geodeindex-like | $79,470 | 9.70% | −29.26% |
| Vanguard Fiduciary Trustindex-like | $53,945 | 6.59% | 0.00% |